ESC: SYNTAX Still Gives Edge to CABG

MedPage Today -- Two-year data from the 1,800-patient SYNTAX trial essentially confirmed the edge given a year ago to coronary artery bypass grafting over stenting to treat complex coronary lesions, researchers said here.